DocGo Inc. Financing Cash Flow
DocGo Inc. (DCGO) reported Financing Cash Flow of -$4.13 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-17
- DocGo Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$1.66M.
- DocGo Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$2.46M.
- DocGo Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$1.86M.
- DocGo Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$33.05M.
- DocGo Inc. net cash provided by (used in) financing activities for fiscal 2025 was -$50.82M.
- DocGo Inc. net cash provided by (used in) financing activities for fiscal 2024 was -$24.15M, a 2259.21% decline from fiscal 2023.
- DocGo Inc. net cash provided by (used in) financing activities for fiscal 2023 was $1.12M.
- DocGo Inc. net cash provided by (used in) financing activities for fiscal 2022 was -$6.18M, a 103.98% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 2 month | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 5 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | -$4.13M 10-Q · filed 2026-08-17 | -$5.99M derived: sum of 3 quarters · filed 2026-08-17 | -$39.04M derived: sum of 4 quarters · filed 2026-08-17 | ||
| 2026-03-31 | -$2.46M 10-Q · filed 2026-05-11 | -$4.33M derived: sum of 2 quarters · filed 2026-05-11 | -$37.38M derived: sum of 3 quarters · filed 2026-05-11 | -$44.76M derived: sum of 4 quarters · filed 2026-08-17 | ||
| 2025-12-31 | -$1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$34.92M derived: sum of 2 quarters · filed 2026-03-16 | -$42.30M derived: sum of 3 quarters · filed 2026-08-17 | -$50.82M 10-K · filed 2026-03-16 | ||
| 2025-09-30 | -$33.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$40.43M derived: sum of 2 quarters · filed 2026-08-17 | -$48.95M 10-Q · filed 2025-11-10 | -$56.81M derived: sum of 4 quarters · filed 2026-08-17 | ||
| 2025-06-30 | -$7.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | -$15.90M 10-Q · filed 2026-08-17 | -$23.76M derived: sum of 3 quarters · filed 2026-08-17 | -$31.11M derived: sum of 4 quarters · filed 2026-08-17 | ||
| 2025-03-31 | -$8.52M 10-Q · filed 2026-05-11 | -$16.37M derived: sum of 2 quarters · filed 2026-05-11 | -$23.73M derived: sum of 3 quarters · filed 2026-05-11 | -$31.79M derived: sum of 4 quarters · filed 2026-05-11 | ||
| 2024-12-31 | -$7.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$15.21M derived: sum of 2 quarters · filed 2026-03-16 | -$23.27M derived: sum of 3 quarters · filed 2026-03-16 | -$24.15M 10-K · filed 2026-03-16 | ||
| 2024-09-30 | -$7.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$15.42M derived: sum of 2 quarters · filed 2025-11-10 | -$16.30M 10-Q · filed 2025-11-10 | -$3.32M derived: sum of 4 quarters · filed 2026-03-16 | ||
| 2024-06-30 | -$8.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$8.95M 10-Q · filed 2025-08-07 | $4.03M derived: sum of 3 quarters · filed 2026-03-16 | -$4.64M derived: sum of 4 quarters · filed 2026-03-16 | ||
| 2024-03-31 | -$881.58K 10-Q · filed 2025-05-08 | $12.10M derived: sum of 2 quarters · filed 2026-03-16 | $3.43M derived: sum of 3 quarters · filed 2026-03-16 | $12.19M derived: sum of 4 quarters · filed 2026-03-16 | ||
| 2023-12-31 | $12.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $4.31M derived: sum of 2 quarters · filed 2026-03-16 | $13.07M derived: sum of 3 quarters · filed 2026-03-16 | $1.12M 10-K · filed 2026-03-16 | ||
| 2023-09-30 | -$8.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $92.53K derived: sum of 2 quarters · filed 2024-11-07 | -$11.86M 10-Q · filed 2024-11-07 | -$18.72M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $8.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$3.19M 10-Q · filed 2024-08-07 | -$10.06M derived: sum of 3 quarters · filed 2025-02-27 | -$10.49M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | -$11.95M 10-Q · filed 2024-05-08 | -$18.82M derived: sum of 2 quarters · filed 2025-02-27 | -$19.25M derived: sum of 3 quarters · filed 2025-02-27 | -$20.63M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | -$6.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$7.30M derived: sum of 2 quarters · filed 2025-02-27 | -$8.68M derived: sum of 3 quarters · filed 2025-02-27 | -$6.18M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | -$436.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$1.81M derived: sum of 2 quarters · filed 2023-11-06 | $685.87K 10-Q · filed 2023-11-06 | $149.76M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | -$1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.12M 10-Q · filed 2023-08-08 | $150.20M derived: sum of 3 quarters · filed 2024-02-28 | $149.28M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $2.50M 10-Q · filed 2023-05-09 | $151.58M derived: sum of 2 quarters · filed 2024-02-28 | $150.65M derived: sum of 3 quarters · filed 2024-02-28 | $158.25M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $149.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $148.16M derived: sum of 2 quarters · filed 2024-02-28 | $155.76M derived: sum of 3 quarters · filed 2024-02-28 | $155.21M 10-K · filed 2024-02-28 | ||
| 2021-09-30 | -$920.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $6.68M derived: sum of 2 quarters · filed 2022-11-08 | $6.13M 10-Q · filed 2022-11-08 | |||
| 2021-06-30 | $7.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $7.05M 10-Q · filed 2022-08-09 | ||||
| 2021-03-31 | -$550.59K 10-Q · filed 2022-05-10 | |||||
| 2020-12-31 | $116.13M 10-K/A · filed 2021-11-24 | -$812.09K 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | $3.60K 10-Q/A · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |